Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$1.18B |
| 2 |
Microsoft
MSFT
|
+$1.11B |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$491M |
| 4 |
Technology Select Sector SPDR Fund
XLK
|
+$464M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$442M |
Top Sells
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.2B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$779M |
| 3 |
DuPont de Nemours
DD
|
+$443M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$359M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| 1 | Technology | 22.43% |
| 2 | Financials | 13.7% |
| 3 | Consumer Discretionary | 10.25% |
| 4 | Communication Services | 9.85% |
| 5 | Healthcare | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Strategy Inc Common Stock Class A
MSTR
$92.5B
| $6.36M | ﹤0.01% |
93,710
-14,300
| -13% | -$971K |
|
1027
ABM Industries
ABM
$2.87B
| $6.36M | ﹤0.01% |
124,663
+43,910
| +54% | +$2.24M |
|
1028
Antero Resources
AR
$10.1B
| $6.36M | ﹤0.01% |
623,008
+258,695
| +71% | +$2.64M |
|
|
NVRO
1029
DELISTED
NEVRO CORP.
NVRO
| $6.32M | ﹤0.01% |
45,330
+19,513
| +76% | +$2.72M |
|
|
JBGS
1030
JBG SMITH
JBGS
$1.44B
| $6.32M | ﹤0.01% |
198,675
+73,860
| +59% | +$2.35M |
|
1031
JetBlue
JBLU
$1.89B
| $6.31M | ﹤0.01% |
310,317
-59,061
| -16% | -$1.2M |
|
1032
Kinross Gold
KGC
$28.3B
| $6.31M | ﹤0.01% |
946,731
-881,447
| -48% | -$5.88M |
|
1033
Avista
AVA
$2.96B
| $6.31M | ﹤0.01% |
132,080
+36,777
| +39% | +$1.76M |
|
|
ALLK
1034
DELISTED
Allakos
ALLK
| $6.29M | ﹤0.01% |
54,780
+5,599
| +11% | +$643K |
|
1035
Agree Realty
ADC
$8.16B
| $6.28M | ﹤0.01% |
93,277
+1,302
| +1% | +$87.6K |
|
1036
The Ensign Group
ENSG
$9.76B
| $6.28M | ﹤0.01% |
66,873
+9,982
| +18% | +$937K |
|
1037
Exponent
EXPO
$3.58B
| $6.27M | ﹤0.01% |
64,290
-7,273
| -10% | -$709K |
|
1038
US Global Jets ETF
JETS
$834M
| $6.26M | ﹤0.01% |
232,691
-659,380
| -74% | -$17.7M |
|
1039
Autoliv
ALV
$9.81B
| $6.26M | ﹤0.01% |
67,409
+28,856
| +75% | +$2.68M |
|
1040
Tetra Tech
TTEK
$9.5B
| $6.22M | ﹤0.01% |
229,240
+110,450
| +93% | +$3M |
|
1041
Freshpet
FRPT
$2.6B
| $6.22M | ﹤0.01% |
39,153
+5,638
| +17% | +$895K |
|
1042
Pacific Biosciences
PACB
$378M
| $6.21M | ﹤0.01% |
186,357
+127,143
| +215% | +$4.24M |
|
1043
Oaktree Specialty Lending
OCSL
$1.22B
| $6.21M | ﹤0.01% |
333,659
-2,500
| -0.7% | -$46.5K |
|
|
CMBT
1044
CMB.TECH NV
CMBT
$2.72B
| $6.2M | ﹤0.01% |
677,753
+43,664
| +7% | +$399K |
|
1045
Murphy USA
MUSA
$7.59B
| $6.19M | ﹤0.01% |
42,839
-25,292
| -37% | -$3.66M |
|
1046
BridgeBio Pharma
BBIO
$10.1B
| $6.17M | ﹤0.01% |
100,219
+63,771
| +175% | +$3.93M |
|
1047
Simply Good Foods
SMPL
$2.78B
| $6.15M | ﹤0.01% |
202,307
+29,441
| +17% | +$895K |
|
|
MTOR
1048
DELISTED
MERITOR, Inc.
MTOR
| $6.15M | ﹤0.01% |
208,957
+15,464
| +8% | +$455K |
|
1049
Owens & Minor
OMI
$422M
| $6.14M | ﹤0.01% |
163,471
-15,357
| -9% | -$577K |
|
1050
Ligand Pharmaceuticals
LGND
$3.26B
| $6.14M | ﹤0.01% |
64,519
+18,415
| +40% | +$1.75M |
|